Chief Operating and of bluebird bio, Inc. (U.S.: Nasdaq:BLUE), Cole Jason, sells 1,584 shares worth $14,893
According to bluebird bio, Inc.'s most recent Statement Of Changes In Beneficial Ownership - Form 4 filing with the SEC dated Jan 12 09:15 PM, company Chief Operating and, Cole Jason disclosed selling 1,584 shares at a cost of $9.40. At the time of this transaction (Jan 10), this trade was worth $14,893 in total. As of Jan 10, Cole Jason now owns 189,575 shares in total worth about $1,632,240.75.
For the last few recent trades made by bluebird bio, Inc. (U.S.: Nasdaq:BLUE) Chief Operating and, Cole Jason, we have the following information:
- SEC Form 4 filing: Jan 11: Sold 3,387 shares at the rate of $9.64 per share. Total worth of this trade was $32,659. Total number of shares owned as of Jan 11 were 186,188
- SEC Form 4 filing: May 03: Sold 38 shares at the rate of $30.15 per share. Total worth of this trade was $1,146. Total number of shares owned as of May 03 were 47,922
- SEC Form 4 filing: Apr 05: Sold 37 shares at the rate of $30.21 per share. Total worth of this trade was $1,118. Total number of shares owned as of Apr 05 were 47,960
Posted by
George Daniels
on Thursday January 13 2022, 3:07 PM EST.
All trademarks acknowledged.
Filed under Business, Stocks.
Comments and Trackbacks closed.
Follow responses:
RSS 2.0
